Document
type: Class

Academic Article
type: Class

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer
most specific type: Academic Article
type: Document
type: Academic Article
type: Article
language: Inglese
type: Thing
type: Continuant
type: Information Content Entity
type: Entity
type: Generically Dependent Continuant
related by: 21068704

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Article
type: Class

RDF description of Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer - http://irises.unilink.it/resource/item/53700
rights: termsOfUse
date: 2026-08-24T05:09:53
publisher: Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer
type: Document

21068704
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer

Information Content Entity
type: Class

Inglese
type: Language